Search

Armata Pharmaceuticals will present positive topline data from the SWARM-P.a. clinical study at the North American Cystic Fibrosis Conference November 3rd in Phoenix, AZ, highlighting results of their novel inhaled multi-phage therapeutic f

Jagdev Singh and colleagues published a clinical trial announcement that will involve a single-arm, open-labelled study investigating the safety and tolerability of intrabronchial and nebulized phage treatment in children with cystic fibros

A new Transplant Infectious Diseases study by Ghady Haidar (University of Pittsburgh School of Medicine) and colleagues reports the use of nebulized phage therapy to treat Burkholderia multivorans in a CF patient. Unfortunately this was a c

Adaptive Phage Therapeutics announced that the first patient has been dosed in the PHAGE clinical trial, evaluating bacteriophage therapy in adults with cystic fibrosis who carry Pseudomonas aeruginosa in their lungs.

The Antibacterial Resistance Leadership Group will begin a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial to examine safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized

Emily’s Entourage, a nonprofit foundation that accelerates research for new treatments and a cure for the final 10% of people with cystic fibrosis, including those with nonsense mutations, announced it has awarded $220,000 in funding to Gra

The National Institute of Allergy and Infectious Diseases (NIAID) has begun a clinical trial for phage therapy in adults with cystic fibrosis, under the leadership of IPATH. The trial plans to enroll 72 participants across 16 cystic fibrosi

PhD Position: Optimizing phage cocktails for treatment of drug-resistant pathogens associated with cystic fibrosis.

IPATH is honored to announce that the Mallory Smith Legacy Fund has directed another generous gift of $50,000 to IPATH that will help to fund important phage therapy research focused on cystic fibrosis patients.

Official trailer for 'Salt in My Soul', a documentary about Mallory Smith, the young woman with CF who passed away in 2017 just before she could receive phage therapy.

Adaptive Phage Therapeutics announced a strategic agreement with the Antibacterial Resistance Leadership Group to support a phase 1b/2 cystic fibrosis (CF) study. The randomized, double-blind, placebo-controlled trial will assess the safety

Register now for the North American Cystic Fibrosis Conference held on November 2-5, by the Cystic Fibrosis Foundation.

[Thanks to the 15+ labs who have responded!! We'll be in touch soon with next steps!] We are urgently seeking Pseudomonas aeruginosa phages for a cystic fibrosis patient in Switzerland. (More than 140 phages have already been tested, but t

Twitter call-out by Steffanie Strathdee, PhD: "If you live in Cambodia & want to participate in a phage hunt to cure superbug infections common in Cystic Fibrosis (CF) patients, contact me, Dr. Saima Aslam or IPATH at IPATH@health.ucsd.edu.

Felix Biotechnology, alongside researchers at Yale University (including labs of Paul Turner, Ben Chan and Jon Koff), are recruiting patients for a cystic fibrosis phage therapy clinical trial! If interested, please contact claire.cochrane@

David Lebeaux (Université de Paris) and colleagues published the first demonstration of phage therapy in a lung-transplanted cystic fibrosis patient infected with pandrug resistant A. xylosoxidans. They successfully carried out two rounds o

We are urgently seeking Extended Spectrum Beta-Lactamase (ESBL) E. coli phages for a cystic fibrosis patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain an

We are urgently seeking Extended Spectrum Beta-Lactamase (ESBL) E. coli phages for a cystic fibrosis patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain an

The FDA has authorized Armata Pharmaceuticals to initiate a phase 1b/2a clinical trial, which they are calling "SWARM-P.a.", to test AP-PA02, its lead phage cocktail candidate, against Pseudomonas aeruginosa airway infections in cystic fibr

Gabriella (Ella) Balasa, a cystic fibrosis (CF) patient who has received phage therapy, and her physician, Nauman Chaudary, have co-authored a unique perspective paper in Pulmonary Therapy about the experience and treatment of a CF patient.